ArticleOncoTargets and therapy2020

MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT Signaling Pathway.

Shengya Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.